World's first medical networking and resource portal

Video Gallery
Member's Video Browser Bookmark


Ranbaxy Laboratories Chairman, CEO and MD Malvinder Mohan Singh on Sunday stepped down, within a year of its acquisition by Japanese giant Daiichi Sankyo, marking an end of family's 48-year long association with the company.

Comments (0)  |   Views (2680)

Community Comments
User Rating
Rate It

Post your comments